Gene-editing technique CRISPR identifies dangerous breast cancer mutations

Mutations in BRCA genes are linked to the early onset of breast and ovarian cancers. But the effect of most mutations is unclear. Now new research can distinguish harmless from dangerous mutations.

CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer - Computational and Structural Biotechnology Journal

Frontiers CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer

John Martin on LinkedIn: CRISPR 'barcodes' map mammalian development in exquisite detail

BRCA mutations can be deadly or harmless. Now CRISPR can tell the difference - Genetic Literacy Project

COVID-19 variants – News, Research and Analysis – The Conversation – page 7

COVID-19 variants – News, Research and Analysis – The Conversation – page 7

Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy, Molecular Cancer

New insights on CRISPR/Cas9-based therapy for breast Cancer, Genes and Environment

Primary steps of CRISPR-Cas-based immunity. The mechanism of

CRISPR - Noticias, Investigaciones y Análisis - The Conversation - página 4

Home – Articles, Analysis, Opinion – The Conversation – page 499

Cells, Free Full-Text

Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy, Molecular Cancer